Amundi S&P Global Health Care ESG UCITS ETF (EPA:GLHL)
France · Delayed Price · Currency is EUR 10.82
+0.01 (0.06%)
At close: Apr 2, 2026
5.05% (1Y)
| Assets | 355.11M |
| Expense Ratio | 0.18% |
| PE Ratio | 22.48 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | n/a |
| Open | 10.77 |
| Previous Close | 10.81 |
| Day's Range | 10.77 - 10.77 |
| 52-Week Low | 9.64 |
| 52-Week High | 11.80 |
| Beta | n/a |
| Holdings | 86 |
| Inception Date | Sep 20, 2022 |
About GLHL
WELS.DE was created on 2022-09-20 by Amundi. The fund's investment portfolio concentrates primarily on health care equity. Sub-Fund: Amundi S&P Global Health Care ESG UCITS ETF (the Sub-Fund) Index: The S&P World Sustainability Enhanced Health Care Index (the Index)
Asset Class Equity
Category Health Care
Stock Exchange Euronext Paris
Ticker Symbol GLHL
Provider Amundi
Index Tracked S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net
Top 10 Holdings
50.89% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.12% |
| AbbVie Inc. | ABBV | 7.23% |
| Merck & Co., Inc. | MRK | 5.08% |
| AstraZeneca PLC | AZN | 4.91% |
| UnitedHealth Group Incorporated | UNH | 4.63% |
| Novartis AG | NOVN | 4.28% |
| Roche Holding AG | ROP | 4.24% |
| Amgen Inc. | AMGN | 3.30% |
| Thermo Fisher Scientific Inc. | TMO | 3.24% |
| Gilead Sciences, Inc. | GILD | 2.86% |